Dr. Petra Popovics (Scientist I/K01 Scholar) in Dr. William Ricke’s laboratory and collaborators at University of Miami demonstrate the potential use for GHRH antagonists for clinical therapy of human cancers and other diseases

In a new publication in Peptides, Dr. Petra Popovics (Scientist I/K01 Scholar in Dr. William Ricke’s laboratory) and colleagues at the University of Miami, demonstrate the potential use of GHRH antagonists for clinical therapy of human cancers and other diseases. See the full publication here: https://pubmed.ncbi.nlm.nih.gov/34952135/